Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus standard-dose oseltamivir for severe influenza and avian influenza
ISRCTN43083885Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2006
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of oseltamivir in influenza and Avian Influenza (AI) (2 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Negative RT-PCR for viral RNA in nose and throat swabs at day 5. Started Oct 2006; status: completed.
02
Drugs
oseltamivir
03
Conditions
influenzaAvian Influenza (AI)
Beyond the preview
Go deeper on ISRCTN43083885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN43083885.